LP
LGL Partners’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,773
| Closed | -$325K | – | 101 |
|
|
2024
Q4 | $325K | Sell |
3,773
-782
| -17% | -$67.3K | 0.05% | 88 |
|
|
2024
Q3 | $542K | Sell |
4,555
-564
| -11% | -$67.2K | 0.08% | 70 |
|
|
2024
Q2 | $731K | Sell |
5,119
-389
| -7% | -$55.5K | 0.11% | 53 |
|
|
2024
Q1 | $707K | Buy |
5,508
+292
| +6% | +$37.5K | 0.12% | 55 |
|
|
2023
Q4 | $540K | Buy |
5,216
+100
| +2% | +$10.3K | 0.07% | 67 |
|
|
2023
Q3 | $465K | Buy |
5,116
+2,558
| +100% | +$233K | 0.08% | 70 |
|
|
2023
Q2 | $414K | Hold |
2,558
| – | – | 0.07% | 75 |
|
|
2023
Q1 | $407K | Sell |
2,558
-901
| -26% | -$143K | 0.07% | 68 |
|
|
2022
Q4 | $468K | Hold |
3,459
| – | – | 0.08% | 59 |
|
|
2022
Q3 | $345K | Sell |
3,459
-70
| -2% | -$6.98K | 0.07% | 80 |
|
|
2022
Q2 | $393K | Sell |
3,529
-697
| -16% | -$77.6K | 0.06% | 64 |
|
|
2022
Q1 | $469K | Buy |
4,226
+245
| +6% | +$27.2K | 0.06% | 58 |
|
|
2021
Q4 | $446K | Hold |
3,981
| – | – | 0.05% | 69 |
|
|
2021
Q3 | $382K | Sell |
3,981
-1,926
| -33% | -$185K | 0.23% | 61 |
|
|
2021
Q2 | $495K | Hold |
5,907
| – | – | 0.3% | 48 |
|
|
2021
Q1 | $398K | Buy |
5,907
+180
| +3% | +$12.1K | 0.23% | 55 |
|
|
2020
Q4 | $400K | Hold |
5,727
| – | – | 0.23% | 55 |
|
|
2020
Q3 | $398K | Sell |
5,727
-51
| -0.9% | -$3.54K | 0.24% | 55 |
|
|
2020
Q2 | $378K | Sell |
5,778
-1,918
| -25% | -$125K | 0.24% | 58 |
|
|
2020
Q1 | $463K | Buy |
7,696
+221
| +3% | +$13.3K | 0.3% | 43 |
|
|
2019
Q4 | $433K | Hold |
7,475
| – | – | 0.14% | 56 |
|
|
2019
Q3 | $386K | Buy |
7,475
+835
| +13% | +$43.1K | 0.16% | 67 |
|
|
2019
Q2 | $339K | Buy |
6,640
+145
| +2% | +$7.4K | 0.13% | 78 |
|
|
2019
Q1 | $340K | Buy |
+6,495
| New | +$340K | 0.13% | 76 |
|